These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 27720608)

  • 1. Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth.
    Lin Z; Guo H; Cao Y; Zohrabian S; Zhou P; Ma Q; VanDusen N; Guo Y; Zhang J; Stevens SM; Liang F; Quan Q; van Gorp PR; Li A; Dos Remedios C; He A; Bezzerides VJ; Pu WT
    Dev Cell; 2016 Nov; 39(4):466-479. PubMed ID: 27720608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.
    Ikeda S; Mizushima W; Sciarretta S; Abdellatif M; Zhai P; Mukai R; Fefelova N; Oka SI; Nakamura M; Del Re DP; Farrance I; Park JY; Tian B; Xie LH; Kumar M; Hsu CP; Sadayappan S; Shimokawa H; Lim DS; Sadoshima J
    Circ Res; 2019 Jan; 124(2):292-305. PubMed ID: 30582455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway.
    Xu K; Zhao H; Qiu X; Liu X; Zhao F; Zhao Y
    Mediators Inflamm; 2020; 2020():8292173. PubMed ID: 33456372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.
    Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N
    FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEAD1 mediates the oncogenic activities of Hippo-YAP1 signaling in osteosarcoma.
    Chai J; Xu S; Guo F
    Biochem Biophys Res Commun; 2017 Jun; 488(2):297-302. PubMed ID: 28483529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
    Ota M; Sasaki H
    Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer.
    Zhang Y; Shen H; Withers HG; Yang N; Denson KE; Mussell AL; Truskinovsky A; Fan Q; Gelman IH; Frangou C; Zhang J
    Sci Rep; 2017 Jul; 7(1):6190. PubMed ID: 28733631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YAP-VGLL4 antagonism defines the major physiological function of the Hippo signaling effector YAP.
    Cai J; Choi K; Li H; Pulgar Prieto KD; Zheng Y; Pan D
    Genes Dev; 2022 Nov-Dec 1; 36(21-24):1119-1128. PubMed ID: 36522128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment.
    Santucci M; Vignudelli T; Ferrari S; Mor M; Scalvini L; Bolognesi ML; Uliassi E; Costi MP
    J Med Chem; 2015 Jun; 58(12):4857-73. PubMed ID: 25719868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex.
    Zhang W; Gao Y; Li P; Shi Z; Guo T; Li F; Han X; Feng Y; Zheng C; Wang Z; Li F; Chen H; Zhou Z; Zhang L; Ji H
    Cell Res; 2014 Mar; 24(3):331-43. PubMed ID: 24458094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling.
    Noland CL; Gierke S; Schnier PD; Murray J; Sandoval WN; Sagolla M; Dey A; Hannoush RN; Fairbrother WJ; Cunningham CN
    Structure; 2016 Jan; 24(1):179-186. PubMed ID: 26724994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity.
    Yao F; Zhou Z; Kim J; Hang Q; Xiao Z; Ton BN; Chang L; Liu N; Zeng L; Wang W; Wang Y; Zhang P; Hu X; Su X; Liang H; Sun Y; Ma L
    Nat Commun; 2018 Jun; 9(1):2269. PubMed ID: 29891922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of TP73 transcription by Hippo-YAP signaling.
    Wen Z; Wang Y; Qi S; Ma M; Li J; Yu FX
    Biochem Biophys Res Commun; 2020 Oct; 531(2):96-104. PubMed ID: 32773110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of VGLL4 Causes Perinatal Lethality without Affecting Myocardial Development.
    Sheldon C; Farley A; Ma Q; Pu WT; Lin Z
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insights into the YAP and TEAD complex.
    Li Z; Zhao B; Wang P; Chen F; Dong Z; Yang H; Guan KL; Xu Y
    Genes Dev; 2010 Feb; 24(3):235-40. PubMed ID: 20123905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo pathway effector Yap promotes cardiac regeneration.
    Xin M; Kim Y; Sutherland LB; Murakami M; Qi X; McAnally J; Porrello ER; Mahmoud AI; Tan W; Shelton JM; Richardson JA; Sadek HA; Bassel-Duby R; Olson EN
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13839-44. PubMed ID: 23918388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP2-SMAD signaling represses the proliferation of embryonic neural stem cells through YAP.
    Yao M; Wang Y; Zhang P; Chen H; Xu Z; Jiao J; Yuan Z
    J Neurosci; 2014 Sep; 34(36):12039-48. PubMed ID: 25186749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TEA domain family transcription factor TEAD4 represses murine adipogenesis by recruiting the cofactors VGLL4 and CtBP2 into a transcriptional complex.
    Zhang W; Xu J; Li J; Guo T; Jiang D; Feng X; Ma X; He L; Wu W; Yin M; Ge L; Wang Z; Ho MS; Zhao Y; Fei Z; Zhang L
    J Biol Chem; 2018 Nov; 293(44):17119-17134. PubMed ID: 30209132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VGLL4 and MENIN function as TEAD1 corepressors to block pancreatic β cell proliferation.
    Li F; Liu R; Negi V; Yang P; Lee J; Jagannathan R; Moulik M; Yechoor VK
    Cell Rep; 2023 Jan; 42(1):111904. PubMed ID: 36662616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.